OverviewSuggest Edit

Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. It operates in two business segments: Pfizer Biopharmaceuticals Group (Biopharma) and Upjohn. The Biopharma segment offers medicines, vaccines, and biosimilars for the treatment of cardiovascular and metabolic diseases, oncology diseases, pneumococcal disease, meningococcal disease and tick-borne encephalitis, chronic immune and inflammatory diseases, as well as rare diseases, including amyloidosis, hemophilia, and endocrine diseases. The Upjohn segment provides products that are used to treat non-communicable diseases across a range of therapeutic areas, including cardiovascular, pain and neurology, psychiatry, urology, and ophthalmology.

TypePublic
Founded1849
HQNew York, NY, US
Websitepfizer.com
Employee Ratings4.2
Overall CultureB

Latest Updates

Employees (est.) (Dec 2019)88,300(-4%)
Job Openings4
Revenue (FY, 2019)$51.8 B(-3%)
Share Price (Jan 2021)$36.7
Cybersecurity ratingCMore

Key People/Management at Pfizer

Albert Bourla

Albert Bourla

Chief Executive Officer
Frank D'Amelio

Frank D'Amelio

Chief Financial Officer and Executive Vice President, Global Supply
Mikael Dolsten

Mikael Dolsten

Chief Scientific Officer and President, Worldwide Research, Development and Medical
Lidia Fonseca

Lidia Fonseca

Chief Digital and Technology Officer, Executive Vice President
Angela Hwang

Angela Hwang

Group President, Pfizer Biopharmaceuticals Group
Rady Johnson

Rady Johnson

Executive Vice President, Chief Compliance, Quality & Risk Officer
Show more

Pfizer Office Locations

Pfizer has offices in New York, Buenos Aires, Villa Adelina, Bentley and in 79 other locations
New York, NY, US (HQ)
235 E 42nd St
Buenos Aires, AR
Carlos Berg 3669
Villa Adelina, AR
Colectora Panamericana 1804
Bentley, AU
15 Brodie-Hall Dr
Melbourne, AU
3/500 Collins St
Mulgrave, AU
1-23 Lexia Pl
Show all (90)

Pfizer Financials and Metrics

Pfizer Revenue

Embed Graph
View revenue for all periods
Pfizer's revenue was reported to be $51.75 b in FY, 2019 which is a 3.5% decrease from the previous period.
USD

Revenue (Q3, 2020)

12.1b

Gross profit (Q3, 2020)

9.6b

Gross profit margin (Q3, 2020), %

79.2%

Net income (Q3, 2020)

2.2b

Market capitalization (15-Jan-2021)

204.0b

Closing stock price (15-Jan-2021)

36.7

Cash (27-Sept-2020)

1.6b

EV

265.6b
Pfizer's current market capitalization is $204 b.
Annual
USDFY, 2017FY, 2018FY, 2019

Revenue

52.5b53.6b51.8b

Revenue growth, %

(1%)2%(4%)

Cost of goods sold

11.2b11.2b10.2b

Gross profit

41.3b42.4b41.5b
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

12.9b13.5b13.3b13.1b13.3b12.7b12.0b11.8b12.1b

Cost of goods sold

2.6b2.9b2.7b2.4b2.6b2.6b2.4b2.3b2.5b

Gross profit

10.3b10.6b10.6b10.7b10.7b10.1b9.7b9.5b9.6b

Gross profit Margin, %

80%78%80%81%81%79%80%81%79%
Annual
USDFY, 2017FY, 2018FY, 2019

Cash

1.3b1.1b1.3b

Accounts Receivable

8.2b8.0b8.7b

Inventories

7.6b7.5b8.3b

Current Assets

41.1b49.9b32.8b
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Cash

2.3b2.7b3.6b1.9b1.8b2.8b2.2b1.8b1.6b

Accounts Receivable

9.5b9.9b10.0b9.6b9.8b9.4b9.9b9.1b10.0b

Inventories

8.1b8.1b8.2b8.0b8.2b8.2b8.4b8.6b9.3b

Current Assets

34.8b37.3b41.6b45.3b47.1b33.5b34.7b46.4b47.7b
Annual
USDFY, 2017FY, 2018FY, 2019

Net Income

21.4b11.2b16.3b

Depreciation and Amortization

6.3b6.4b6.0b

Inventories

(357.0m)(717.0m)(1.0b)

Accounts Payable

46.0m431.0m(564.0m)
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Net Income

3.6b7.4b11.6b3.9b8.9b16.6b3.4b6.8b9.0b

Depreciation and Amortization

1.6b3.1b4.7b1.5b3.1b4.6b1.2b2.5b3.7b

Cash From Operating Activities

2.0b5.8b11.1b1.7b4.3b8.8b3.1b6.7b8.8b

Purchases of PP&E

(386.0m)(810.0m)(1.4b)(460.0m)(939.0m)(1.5b)(463.0m)(942.0m)(1.5b)
USDFY, 2017

EV/CFO

15.7 x

Revenue/Employee

582.5k

Debt/Equity

0.6 x

Debt/Assets

0.3 x

Financial Leverage

2.4 x

P/E Ratio

10.2
Show all financial metrics

Pfizer Operating Metrics

Pfizer's Properties was reported to be 453 in FY, 2019.
FY, 2017FY, 2018FY, 2019

Countries

125 125 125

Manufacturing Sites

58 58 49

Properties

501 498 453

Products with >$1B Annual Revenue

9 10 8
Show all operating metrics

Pfizer Acquisitions / Subsidiaries

Company NameDateDeal Size
Array BioPharmaJune 18, 2019$11.40 b
TherachonMay 08, 2019$340 m
MedivationAugust 22, 2016$14 b
Bamboo TherapeuticsAugust 01, 2016$654 m
BIND Therapeutics, Inc.July 27, 2016$40 m
Anacor PharmaceuticalsJune 24, 2016$5.20 b
HospiraFebruary 05, 2015$15 b
RedvaxJanuary 05, 2015
Baxter International - Marketed VaccinesJuly 30, 2014$635 m
InnoPharmaJuly 16, 2014$225 m
Show more

Pfizer Revenue Breakdown

Embed Graph

Pfizer revenue breakdown by business segment: 19.8% from Upjohn, 76.2% from Biopharma and 4.1% from Other

Pfizer revenue breakdown by geographic segment: 16.8% from Developed Europe, 46.1% from United States, 24.6% from Emerging Markets and 12.5% from Developed Rest of World

Pfizer Cybersecurity Score

Cybersecurity ratingPremium dataset

C

79/100

SecurityScorecard logo

Pfizer Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

CSRHub logo

Pfizer Online and Social Media Presence

Embed Graph

Pfizer Company Culture

  • Overall Culture

    B

    69/100

  • CEO Rating

    C+

    68/100

  • Compensation

    B

    72/100

  • Diversity

    B-

    68/100

Learn more on Comparably

Pfizer News and Updates

Dow skids to session low Friday morning amid report that Pfizer vaccines in EU may face delays

U.S. stock market indexes Friday morning were trading at or near sessions lows after a report indicated some delays in the distribution of vaccines from Pfizer in Europe. AFP reported that the European Union's Pfizer vaccine deliveries could be delayed 'for next 3-4 weeks.' The Dow was trading off …

Thinking about trading options or stock in Axon Enterprise, Tilray, Pfizer, Crispr Therapeutics, or General Motors?

NEW YORK, Jan. 15, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAXN, TLRY, PFE, CRSP, and GM. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report – Ideal trade ideas on up to seven different...

Pfizer to temporarily reduce vaccine deliveries to UK and EU

Pfizer will temporarily reduce deliveries of its Covid vaccine to the UK and across Europe from next week, according to The post Pfizer to temporarily reduce vaccine deliveries to UK and EU appeared first on CityAM.

European Pharmaceutical Contract Development and Manufacturing Organization Market Outlook to 2030, Featuring Aenova Group, Baxter BioPharma Solutions, Catalent Inc, Pfizer CentreSource and More.

Dublin, Jan. 15, 2021 (GLOBE NEWSWIRE) -- The "Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market 2020-2030 by Category, Service Type (CMO, CRO), Therapeutic Application, End User, and Country" report has been added to ResearchAndMarkets.com's offering. The E…

Japan Seeks Mid-February Pfizer Vaccine Approval, Minister Says

Japan Seeks Mid-February Pfizer Vaccine Approval, Minister Says

Podcast: The vaccine pipeline, beyond Pfizer and Moderna

America has become a two-vaccine nation, but plenty of other companies are continuing to work on new vaccines that could increase supply and accelerate the country's goal of herd immunity.Axios Re:Cap digs into the vaccine pipeline with Derek Lowe, a medicinal chemist and biotech blogger.
Show more

Pfizer Blogs

INDEPENDENT MEDICAL EDUCATION

INDEPENDENT MEDICAL EDUCATION kimkevin Sat, 12/26/2020 - 19:36 Pfizer offers funding for independent medical education activities or initiatives which serve to maintain, develop, or increase the knowledge, skills, and/or professional performance of a healthcare professional (e.g. conti…

Pfizer Frequently Asked Questions

  • When was Pfizer founded?

    Pfizer was founded in 1849.

  • Who are Pfizer key executives?

    Pfizer's key executives are Albert Bourla, Frank D'Amelio and Mikael Dolsten.

  • How many employees does Pfizer have?

    Pfizer has 88,300 employees.

  • What is Pfizer revenue?

    Latest Pfizer annual revenue is $51.8 b.

  • What is Pfizer revenue per employee?

    Latest Pfizer revenue per employee is $586.1 k.

  • Who are Pfizer competitors?

    Competitors of Pfizer include Bayer, GSK and Eli Lilly.

  • Where is Pfizer headquarters?

    Pfizer headquarters is located at 235 E 42nd St, New York.

  • Where are Pfizer offices?

    Pfizer has offices in New York, Buenos Aires, Villa Adelina, Bentley and in 79 other locations.

  • How many offices does Pfizer have?

    Pfizer has 90 offices.